Abstract Poster Session News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Abstract Poster Session. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Abstract Poster Session Today - Breaking & Trending Today

argenx to Highlight Potential First-in-Class FcRn Antagonist Efgartigimod at Upcoming Neuromuscular Meetings

Published: October 8, 2021

Argenx to Highlight Potential First-in-Class FcRn Antagonist Efgartigimod at Upcoming Neuromuscular Meetings - read this article along with other careers information, tips and advice on BioSpace

Source: biospace.com

Related Topics:

United StatesChafic KaramMichelle GreenblattGregoryw FultonDemyelinating PolyneuropathyJeffrey GuptillGlenn PhillipsKelsey KirkNicholasj SilvestriWim ParysGil WolfePeter DonofrioTuan VuBeth DelgiaccoNeelam GoyalUniversity Health NetworkUniversity Of South FloridaNeuromuscular CenterMyasthenia Gravis Foundation Of America Scientific SessionUniversity Of TorontoHealth EconomicsVanderbilt UniversityResearch Initiative AwardImmunology Innovation ProgramAmerican Association Of Neuromuscular